Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease

Amnon Sonnenberg, Shelby D. Melton, Robert M. Genta

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Background: The purpose was to study the epidemiology of Helicobacter-negative gastritis among a large group of patients with inflammatory bowel disease (IBD) and healthy controls. Methods: From a computerized database of surgical pathology reports we selected 5493 patients who underwent colonoscopy and upper gastrointestinal endoscopy with biopsy results from both procedures. The presence of gastritis and duodenitis was compared among 550 case subjects with IBD and 4943 healthy control subjects. The results are expressed as prevalence rates, as well as age- and sex-adjusted odds ratios with 95% confidence intervals. Results: Any type gastritis was found in 13% of controls and 25% of IBD patients (Crohn's disease [CD] 33%, ulcerative colitis [UC] 19%). Duodenitis was found in 1% of controls and 13% of IBD patients (CD 26%, UC 3%). In subjects younger than 18 years the prevalence of gastritis and duodenitis were 53% and 40% in CD, respectively, and 38% and 0% in UC, respectively. Similar prevalence rates were found in men and women. The odds ratio for Helicobacter-negative chronic active gastritis associated with CD was 11.7 (7.5-18.0) and with UC 2.8 (1.4-5.0). The corresponding values for focally enhanced gastritis were 40.1 (15.5-114.9) in CD and 0 in UC. Conclusions: Helicobacter-negative gastritis and duodenitis occur significantly more often in patients with IBD than healthy controls. Such upper gastrointestinal inflammation appears to be particularly common in CD and younger patients.

Original languageEnglish (US)
Pages (from-to)39-44
Number of pages6
JournalInflammatory Bowel Diseases
Volume17
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Duodenitis
Gastritis
Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis
Helicobacter
Odds Ratio
Surgical Pathology
Gastrointestinal Endoscopy
Colonoscopy
Healthy Volunteers
Epidemiology
Databases
Confidence Intervals
Inflammation
Biopsy

Keywords

  • chronic active gastritis
  • Crohn's disease
  • duodenitis
  • epidemiology of gastritis
  • Helicobacter pylori
  • ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease. / Sonnenberg, Amnon; Melton, Shelby D.; Genta, Robert M.

In: Inflammatory Bowel Diseases, Vol. 17, No. 1, 01.2011, p. 39-44.

Research output: Contribution to journalArticle

@article{01bd6bafd93c468db081710c3f645b6c,
title = "Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease",
abstract = "Background: The purpose was to study the epidemiology of Helicobacter-negative gastritis among a large group of patients with inflammatory bowel disease (IBD) and healthy controls. Methods: From a computerized database of surgical pathology reports we selected 5493 patients who underwent colonoscopy and upper gastrointestinal endoscopy with biopsy results from both procedures. The presence of gastritis and duodenitis was compared among 550 case subjects with IBD and 4943 healthy control subjects. The results are expressed as prevalence rates, as well as age- and sex-adjusted odds ratios with 95{\%} confidence intervals. Results: Any type gastritis was found in 13{\%} of controls and 25{\%} of IBD patients (Crohn's disease [CD] 33{\%}, ulcerative colitis [UC] 19{\%}). Duodenitis was found in 1{\%} of controls and 13{\%} of IBD patients (CD 26{\%}, UC 3{\%}). In subjects younger than 18 years the prevalence of gastritis and duodenitis were 53{\%} and 40{\%} in CD, respectively, and 38{\%} and 0{\%} in UC, respectively. Similar prevalence rates were found in men and women. The odds ratio for Helicobacter-negative chronic active gastritis associated with CD was 11.7 (7.5-18.0) and with UC 2.8 (1.4-5.0). The corresponding values for focally enhanced gastritis were 40.1 (15.5-114.9) in CD and 0 in UC. Conclusions: Helicobacter-negative gastritis and duodenitis occur significantly more often in patients with IBD than healthy controls. Such upper gastrointestinal inflammation appears to be particularly common in CD and younger patients.",
keywords = "chronic active gastritis, Crohn's disease, duodenitis, epidemiology of gastritis, Helicobacter pylori, ulcerative colitis",
author = "Amnon Sonnenberg and Melton, {Shelby D.} and Genta, {Robert M.}",
year = "2011",
month = "1",
doi = "10.1002/ibd.21356",
language = "English (US)",
volume = "17",
pages = "39--44",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease

AU - Sonnenberg, Amnon

AU - Melton, Shelby D.

AU - Genta, Robert M.

PY - 2011/1

Y1 - 2011/1

N2 - Background: The purpose was to study the epidemiology of Helicobacter-negative gastritis among a large group of patients with inflammatory bowel disease (IBD) and healthy controls. Methods: From a computerized database of surgical pathology reports we selected 5493 patients who underwent colonoscopy and upper gastrointestinal endoscopy with biopsy results from both procedures. The presence of gastritis and duodenitis was compared among 550 case subjects with IBD and 4943 healthy control subjects. The results are expressed as prevalence rates, as well as age- and sex-adjusted odds ratios with 95% confidence intervals. Results: Any type gastritis was found in 13% of controls and 25% of IBD patients (Crohn's disease [CD] 33%, ulcerative colitis [UC] 19%). Duodenitis was found in 1% of controls and 13% of IBD patients (CD 26%, UC 3%). In subjects younger than 18 years the prevalence of gastritis and duodenitis were 53% and 40% in CD, respectively, and 38% and 0% in UC, respectively. Similar prevalence rates were found in men and women. The odds ratio for Helicobacter-negative chronic active gastritis associated with CD was 11.7 (7.5-18.0) and with UC 2.8 (1.4-5.0). The corresponding values for focally enhanced gastritis were 40.1 (15.5-114.9) in CD and 0 in UC. Conclusions: Helicobacter-negative gastritis and duodenitis occur significantly more often in patients with IBD than healthy controls. Such upper gastrointestinal inflammation appears to be particularly common in CD and younger patients.

AB - Background: The purpose was to study the epidemiology of Helicobacter-negative gastritis among a large group of patients with inflammatory bowel disease (IBD) and healthy controls. Methods: From a computerized database of surgical pathology reports we selected 5493 patients who underwent colonoscopy and upper gastrointestinal endoscopy with biopsy results from both procedures. The presence of gastritis and duodenitis was compared among 550 case subjects with IBD and 4943 healthy control subjects. The results are expressed as prevalence rates, as well as age- and sex-adjusted odds ratios with 95% confidence intervals. Results: Any type gastritis was found in 13% of controls and 25% of IBD patients (Crohn's disease [CD] 33%, ulcerative colitis [UC] 19%). Duodenitis was found in 1% of controls and 13% of IBD patients (CD 26%, UC 3%). In subjects younger than 18 years the prevalence of gastritis and duodenitis were 53% and 40% in CD, respectively, and 38% and 0% in UC, respectively. Similar prevalence rates were found in men and women. The odds ratio for Helicobacter-negative chronic active gastritis associated with CD was 11.7 (7.5-18.0) and with UC 2.8 (1.4-5.0). The corresponding values for focally enhanced gastritis were 40.1 (15.5-114.9) in CD and 0 in UC. Conclusions: Helicobacter-negative gastritis and duodenitis occur significantly more often in patients with IBD than healthy controls. Such upper gastrointestinal inflammation appears to be particularly common in CD and younger patients.

KW - chronic active gastritis

KW - Crohn's disease

KW - duodenitis

KW - epidemiology of gastritis

KW - Helicobacter pylori

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=78650118402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650118402&partnerID=8YFLogxK

U2 - 10.1002/ibd.21356

DO - 10.1002/ibd.21356

M3 - Article

C2 - 20848539

AN - SCOPUS:78650118402

VL - 17

SP - 39

EP - 44

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 1

ER -